By Rachel Cohrs Zhang and Madison Muller
The Trump administration announced a crackdown on pharmaceutical advertising on television and social media platforms, potentially disrupting billions of dollars in annual ad spending.
President Donald Trump signed a presidential memorandum on Tuesday that calls on federal health agencies to require pharmaceutical companies to disclose more side effects in their ads and enforce existing rules about misleading ads. The administration is pitching the moves as a way to increase transparency for patients.
The US is the only place, besides New Zealand, where pharma companies can directly advertise to consumers. Limiting pharmaceutical advertisements has been a longtime priority for Health and Human Services Secretary Robert F. Kennedy Jr., though the new regulations would stop short of banning the ads entirely.
But even adding stricter requirements to the ads will likely hit both pharmaceutical companies and the media companies that rely heavily on those advertising dollars.
Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components
This article originally appeared here and was republished with permission.
